137 related articles for article (PubMed ID: 14749683)
1. Acute oxidative stress induces peritoneal hyperpermeability, mesothelial loss, and fibrosis.
Gotloib L; Wajsbrot V; Cuperman Y; Shostak A
J Lab Clin Med; 2004 Jan; 143(1):31-40. PubMed ID: 14749683
[TBL] [Abstract][Full Text] [Related]
2. A short review of experimental peritoneal sclerosis: from mice to men.
Gotloib L; Wajsbrot V; Shostak A
Int J Artif Organs; 2005 Feb; 28(2):97-104. PubMed ID: 15770597
[TBL] [Abstract][Full Text] [Related]
3. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
[TBL] [Abstract][Full Text] [Related]
4. Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?
Bozkurt D; Hur E; Ulkuden B; Sezak M; Nar H; Purclutepe O; Sen S; Duman S
Perit Dial Int; 2009 Feb; 29 Suppl 2():S202-5. PubMed ID: 19270218
[TBL] [Abstract][Full Text] [Related]
5. Osmotic agents hamper mesothelial repopulation as seen in the doughnut in vivo model.
Gotloib L; Wajsbrot V; Shostak A
Perit Dial Int; 2005 Feb; 25 Suppl 3():S26-30. PubMed ID: 16048251
[TBL] [Abstract][Full Text] [Related]
6. Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
Kakuta T; Tanaka R; Satoh Y; Izuhara Y; Inagi R; Nangaku M; Saito A; Miyata T
Kidney Int; 2005 Sep; 68(3):1326-36. PubMed ID: 16105068
[TBL] [Abstract][Full Text] [Related]
7. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
8. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats.
Breborowicz A; Polubinska A; Moberly J; Ogle K; Martis L; Oreopoulos D
Am J Kidney Dis; 2001 Mar; 37(3):594-600. PubMed ID: 11228185
[TBL] [Abstract][Full Text] [Related]
10. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
11. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
13. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
14. Glucose suppresses peritoneal inflammatory reactions and mesothelial hyperplasia caused by intraperitoneal saline infusion.
Styszynski A; Podkowka R; Wieczorowska-Tobis K; Kwiatkowska B; Ksiazek K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2002; 18():21-5. PubMed ID: 12402581
[TBL] [Abstract][Full Text] [Related]
15. Mediators of inflammation and fibrosis.
Lai KN; Tang SC; Leung JC
Perit Dial Int; 2007 Jun; 27 Suppl 2():S65-71. PubMed ID: 17556333
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional alterations of the peritoneum after prolonged exposure to dialysis solutions: role of aminoguanidine.
Lee EA; Oh JH; Lee HA; Kim SI; Park EW; Park KB; Park MS
Perit Dial Int; 2001; 21(3):245-53. PubMed ID: 11475339
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
18. Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury.
Verger C; Luger A; Moore HL; Nolph KD
Kidney Int; 1983 Jun; 23(6):823-31. PubMed ID: 6887693
[TBL] [Abstract][Full Text] [Related]
19. Multidirectional approach to study peritoneal dialysis fluid biocompatibility in a chronic peritoneal dialysis model in the rat.
Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Pawlaczyk K; Kuzlan-Pawlaczyk M; Filas V; Breborowicz A; Oreopoulos DG
Nephrol Dial Transplant; 2001 Mar; 16(3):655-6. PubMed ID: 11239060
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis.
Ferrier ML; Combet S; van Landschoot M; Stoenoiu MS; Cnops Y; Lameire N; Devuyst O
Kidney Int; 2001 Dec; 60(6):2343-50. PubMed ID: 11737609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]